These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 19318153)
1. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Byers BD; Betancourt A; Lu F; Hankins GD; Longo M; Saade GR; Bytautiene E Am J Obstet Gynecol; 2009 Apr; 200(4):432.e1-7. PubMed ID: 19318153 [TBL] [Abstract][Full Text] [Related]
2. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. McDonnold M; Tamayo E; Kechichian T; Gamble P; Longo M; Hankins GD; Saade GR; Costantine MM Am J Obstet Gynecol; 2014 Jun; 210(6):542.e1-7. PubMed ID: 24412113 [TBL] [Abstract][Full Text] [Related]
3. Prepregnancy obesity and sFlt1-induced preeclampsia in mice: developmental programming model of metabolic syndrome. Bytautiene E; Tamayo E; Kechichian T; Drever N; Gamble P; Hankins GD; Saade GR Am J Obstet Gynecol; 2011 May; 204(5):398.e1-8. PubMed ID: 21444063 [TBL] [Abstract][Full Text] [Related]
4. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Lu F; Bytautiene E; Tamayo E; Gamble P; Anderson GD; Hankins GD; Longo M; Saade GR Am J Obstet Gynecol; 2007 Oct; 197(4):418.e1-5. PubMed ID: 17904985 [TBL] [Abstract][Full Text] [Related]
5. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Fox KA; Longo M; Tamayo E; Kechichian T; Bytautiene E; Hankins GD; Saade GR; Costantine MM Am J Obstet Gynecol; 2011 Oct; 205(4):366.e1-5. PubMed ID: 22083058 [TBL] [Abstract][Full Text] [Related]
6. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Costantine MM; Tamayo E; Lu F; Bytautiene E; Longo M; Hankins GDV; Saade GR Obstet Gynecol; 2010 Jul; 116(1):114-120. PubMed ID: 20567176 [TBL] [Abstract][Full Text] [Related]
7. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Lu F; Longo M; Tamayo E; Maner W; Al-Hendy A; Anderson GD; Hankins GD; Saade GR Am J Obstet Gynecol; 2007 Apr; 196(4):396.e1-7; discussion 396.e7. PubMed ID: 17403433 [TBL] [Abstract][Full Text] [Related]
8. Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia. Saad AF; Diken ZM; Kechichian TB; Clark SM; Olson GL; Saade GR; Costantine MM Reprod Sci; 2016 Nov; 23(11):1593-1599. PubMed ID: 27170663 [TBL] [Abstract][Full Text] [Related]
9. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Kim YN; Lee DS; Jeong DH; Sung MS; Kim KT Prenat Diagn; 2009 May; 29(5):464-70. PubMed ID: 19242927 [TBL] [Abstract][Full Text] [Related]
10. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Bytautiene E; Lu F; Tamayo EH; Hankins GD; Longo M; Kublickiene K; Saade GR Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H189-93. PubMed ID: 19915174 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells. Nakada E; Walley KR; Nakada T; Hu Y; von Dadelszen P; Boyd JH Placenta; 2009 Sep; 30(9):774-9. PubMed ID: 19631980 [TBL] [Abstract][Full Text] [Related]
12. Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model. Carver AR; Andrikopoulou M; Lei J; Tamayo E; Gamble P; Hou Z; Zhang J; Mori S; Saade GR; Costantine MM; Burd I PLoS One; 2014; 9(6):e100873. PubMed ID: 24963809 [TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization. Min Z; Qiang W; Benwen S; Bin L; Xinhua D Curr Eye Res; 2009 May; 34(5):401-10. PubMed ID: 19401884 [TBL] [Abstract][Full Text] [Related]
14. Effects of curcuminoid supplement on cardiac autonomic status in high-fat-induced obese rats. Pongchaidecha A; Lailerd N; Boonprasert W; Chattipakorn N Nutrition; 2009; 25(7-8):870-8. PubMed ID: 19398300 [TBL] [Abstract][Full Text] [Related]
15. In utero programming of adult vascular function in transgenic mice lacking low-density lipoprotein receptor. Langenveld J; Lu F; Bytautiene E; Anderson GD; Saade GR; Longo M Am J Obstet Gynecol; 2008 Aug; 199(2):165.e1-5. PubMed ID: 18359469 [TBL] [Abstract][Full Text] [Related]
16. Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1. Mateus J; Bytautiene E; Lu F; Tamayo EH; Betancourt A; Hankins GD; Longo M; Saade GR Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1781-7. PubMed ID: 21890691 [TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake. Falcao S; Bisotto S; Gutkowska J; Lavoie JL Am J Obstet Gynecol; 2009 Feb; 200(2):198.e1-5. PubMed ID: 19110222 [TBL] [Abstract][Full Text] [Related]
18. Placental ischemia and breast cancer risk after preeclampsia: tying the knot. Gingery A; Bahe EL; Gilbert JS Expert Rev Anticancer Ther; 2009 May; 9(5):671-81. PubMed ID: 19445583 [TBL] [Abstract][Full Text] [Related]
19. Novel splice variants of sFlt1 are upregulated in preeclampsia. Heydarian M; McCaffrey T; Florea L; Yang Z; Ross MM; Zhou W; Maynard SE Placenta; 2009 Mar; 30(3):250-5. PubMed ID: 19147226 [TBL] [Abstract][Full Text] [Related]
20. In utero sFlt-1 exposure differentially affects gene expression patterns in fetal liver. Stojanovska V; Holwerda KM; van der Graaf AM; Verkaik-Schakel RN; Boekschoten MV; Faas MM; Scherjon SA; Plösch T J Dev Orig Health Dis; 2019 Jun; 10(3):353-361. PubMed ID: 30968813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]